China Shineway Pharmaceutical Group 관리
관리 기준 확인 1/4
현재 CEO에 대한 정보가 충분하지 않습니다.
주요 정보
최고 경영자
n/a
총 보상
CEO 급여 비율 | n/a |
CEO 임기 | no data |
CEO 소유권 | n/a |
경영진 평균 재임 기간 | 데이터 없음 |
이사회 평균 재임 기간 | 4.1yrs |
최근 관리 업데이트
Recent updates
China Shineway Pharmaceutical Group Limited's (HKG:2877) Price Is Right But Growth Is Lacking After Shares Rocket 27%
Oct 18If EPS Growth Is Important To You, China Shineway Pharmaceutical Group (HKG:2877) Presents An Opportunity
Jun 03Is China Shineway Pharmaceutical Group (HKG:2877) A Risky Investment?
May 13China Shineway Pharmaceutical Group (HKG:2877) Has Announced That It Will Be Increasing Its Dividend To CN¥0.461
Apr 26Are Investors Undervaluing China Shineway Pharmaceutical Group Limited (HKG:2877) By 41%?
Apr 17China Shineway Pharmaceutical Group (HKG:2877) Is Increasing Its Dividend To CN¥0.461
Mar 31China Shineway Pharmaceutical Group Limited's (HKG:2877) 26% Price Boost Is Out Of Tune With Earnings
Mar 14Does China Shineway Pharmaceutical Group (HKG:2877) Deserve A Spot On Your Watchlist?
Jan 29China Shineway Pharmaceutical Group (HKG:2877) Seems To Use Debt Rather Sparingly
Sep 28China Shineway Pharmaceutical Group (HKG:2877) Is Paying Out A Dividend Of CN¥0.118
Sep 01We Ran A Stock Scan For Earnings Growth And China Shineway Pharmaceutical Group (HKG:2877) Passed With Ease
Aug 03Are Investors Undervaluing China Shineway Pharmaceutical Group Limited (HKG:2877) By 44%?
May 30We Ran A Stock Scan For Earnings Growth And China Shineway Pharmaceutical Group (HKG:2877) Passed With Ease
Mar 07China Shineway Pharmaceutical Group's (HKG:2877) Dividend Will Be Reduced To CN¥0.125
Sep 01China Shineway Pharmaceutical Group Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Mar 31China Shineway Pharmaceutical Group (HKG:2877) Has A Rock Solid Balance Sheet
Apr 07China Shineway Pharmaceutical Group's(HKG:2877) Share Price Is Down 55% Over The Past Three Years.
Mar 11Should You Buy China Shineway Pharmaceutical Group Limited (HKG:2877) For Its Dividend?
Feb 18Should You Use China Shineway Pharmaceutical Group's (HKG:2877) Statutory Earnings To Analyse It?
Jan 31Is China Shineway Pharmaceutical Group Limited (HKG:2877) Trading At A 49% Discount?
Jan 13What Is The Ownership Structure Like For China Shineway Pharmaceutical Group Limited (HKG:2877)?
Dec 25We Think China Shineway Pharmaceutical Group (HKG:2877) Can Manage Its Debt With Ease
Dec 10Reflecting on China Shineway Pharmaceutical Group's (HKG:2877) Share Price Returns Over The Last Five Years
Nov 25CEO
China Shineway Pharmaceutical Group 에는 CEO가 없거나 그에 대한 데이터가 없습니다.
이사회 구성원
이름 | 위치 | 테뉴어 | 보상 | 소유권 |
---|---|---|---|---|
Co-Founder & Executive Chairman | 22.1yrs | CN¥25.64m | 72.39% HK$ 4.4b | |
Co-Founder & Executive Director | 20.3yrs | CN¥13.20m | 0.071% HK$ 4.4m | |
Executive Director | 20.3yrs | CN¥2.12m | 0.14% HK$ 8.3m | |
Independent Non-Executive Director | 3yrs | CN¥142.00k | 데이터 없음 | |
Independent Non-Executive Director | 1.6yrs | CN¥106.00k | 데이터 없음 | |
Non-Executive Director | 4.1yrs | CN¥142.00k | 데이터 없음 | |
Independent Non-Executive Director | 2.1yrs | CN¥142.00k | 데이터 없음 |
4.1yrs
평균 재임 기간
56yo
평균 연령
경험이 풍부한 이사회: 2877 의 이사회는 경험(평균 재직 기간 4.1 년)으로 간주됩니다.